Remedium Lifecare Posts Strong Q2 And H1 Growth Momentum
ECONOMY & POLICY

Remedium Lifecare Posts Strong Q2 And H1 Growth Momentum

Remedium Lifecare Limited has announced its consolidated financial results for the quarter and half-year ended 30 September 2025, reporting strong operational momentum and continued progress in business expansion.

For Q2 FY26, consolidated revenue from operations stood at Rs 1.11 billion, while total income reached Rs 1.14 billion. The company reported consolidated profit before tax of Rs 104.37 million and profit after tax of Rs 38.62 million. Earnings per share were Rs 0.10, doubling from Q1 FY26.

For the half-year period, consolidated revenue from operations totalled Rs 2.24 billion, with total income at Rs 2.31 billion. Profit before tax for H1 FY26 was Rs 316.49 million, and profit after tax reached Rs 132.72 million, translating to earnings per share of Rs 0.15. Consolidated total assets stood at Rs 16.23 billion as of 30 September 2025.

Commenting on the results, Mr Adarsh Munjal, Whole-Time Director, said the second-quarter performance reflected the company’s ongoing commitment to operational discipline and strategic expansion. He noted that the consolidated results demonstrate the strength of the company’s portfolio and its ability to scale efficiently. He added that the company expects momentum to continue through the remainder of the financial year as it focuses on profitability, asset strengthening, and sustainable growth.

Remedium Lifecare has recently strengthened its leadership with the appointment of Mr Rambhajan Vishwakarma and Mr Vignesh Laxman Gawde to the Board, signalling enhanced focus on governance, global expansion, and scaling of CDMO capabilities.

The company’s broader strategy—leveraging its global-subsidiary network, including a Singapore entity incorporated in September 2024, and expanding its CDMO service offerings—reinforces its ambition to strengthen and monetise its specialty pharmaceuticals and chemicals business

Remedium Lifecare Limited has announced its consolidated financial results for the quarter and half-year ended 30 September 2025, reporting strong operational momentum and continued progress in business expansion. For Q2 FY26, consolidated revenue from operations stood at Rs 1.11 billion, while total income reached Rs 1.14 billion. The company reported consolidated profit before tax of Rs 104.37 million and profit after tax of Rs 38.62 million. Earnings per share were Rs 0.10, doubling from Q1 FY26. For the half-year period, consolidated revenue from operations totalled Rs 2.24 billion, with total income at Rs 2.31 billion. Profit before tax for H1 FY26 was Rs 316.49 million, and profit after tax reached Rs 132.72 million, translating to earnings per share of Rs 0.15. Consolidated total assets stood at Rs 16.23 billion as of 30 September 2025. Commenting on the results, Mr Adarsh Munjal, Whole-Time Director, said the second-quarter performance reflected the company’s ongoing commitment to operational discipline and strategic expansion. He noted that the consolidated results demonstrate the strength of the company’s portfolio and its ability to scale efficiently. He added that the company expects momentum to continue through the remainder of the financial year as it focuses on profitability, asset strengthening, and sustainable growth. Remedium Lifecare has recently strengthened its leadership with the appointment of Mr Rambhajan Vishwakarma and Mr Vignesh Laxman Gawde to the Board, signalling enhanced focus on governance, global expansion, and scaling of CDMO capabilities. The company’s broader strategy—leveraging its global-subsidiary network, including a Singapore entity incorporated in September 2024, and expanding its CDMO service offerings—reinforces its ambition to strengthen and monetise its specialty pharmaceuticals and chemicals business

Next Story
Equipment

HKSTP Invests in Vizzio to Advance AI and Smart City Innovation

Hong Kong Science & Technology Parks Corporation (HKSTP) has announced a strategic investment and partnership with Singapore-based Vizzio Technologies, a global player in 3D mapping and AI-powered security solutions. The agreement was formalised at a signing event at Hong Kong Science Park and includes an investment by HKSTP through its Corporate Venture Fund (CVF) as well as the establishment of Vizzio’s new office at the park, focused on research and development, artificial intelligence, and marketing.The collaboration is aimed at accelerating Vizzio’s international expansion while s..

Next Story
Equipment

TrucksUp Elevates Wahid Raza as CBO to Drive Strategic Growth

Gurugram-based logistics aggregator platform TrucksUp has announced the elevation of Wahid Raza to the position of Chief Business Officer (CBO), marking a key leadership move as the company gears up for its next phase of strategic expansion and operational scale-up.Raza brings with him extensive experience spanning business development, sales, operations, compliance, and strategic planning. During his tenure at TrucksUp, he has played a critical role in strengthening internal business processes, fostering cross-functional collaboration, and building governance frameworks that support scalable ..

Next Story
Equipment

Schwing Stetter India Unveils New Innovations at Excon 2025

Schwing Stetter India unveiled more than 20 new machines at Excon 2025, marking one of its most significant showcases and introducing several India-first technologies to the construction equipment sector. The company launched the country’s first 56-metre boom pump designed and manufactured in India, the first fully electric truck mixer, the first CNG mixer variant and the first hybrid boom pump. Executives said the launch portfolio was engineered to support India’s move toward faster, greener and more vertically oriented infrastructure through advanced engineering, clean-energy solutions a..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Open In App